ATROPINE Drug Patent Profile
✉ Email this page to a colleague
When do Atropine patents expire, and what generic alternatives are available?
Atropine is a drug marketed by Abbvie, Rafa Labs Ltd, Us Army, Amneal, Apotex, Bausch And Lomb Inc, Mankind Pharma, Rising, Somerset, Accord Hlthcare, Am Regent, Hospira, Intl Medication Sys, Medefil Inc, Fresenius Kabi Usa, and Hikma. and is included in twenty-two NDAs.
The generic ingredient in ATROPINE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atropine
A generic version of ATROPINE was approved as atropine sulfate by HOSPIRA on July 9th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATROPINE?
- What are the global sales for ATROPINE?
- What is Average Wholesale Price for ATROPINE?
Summary for ATROPINE
US Patents: | 0 |
Applicants: | 16 |
NDAs: | 22 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Clinical Trials: | 416 |
Patent Applications: | 3,664 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ATROPINE |
What excipients (inactive ingredients) are in ATROPINE? | ATROPINE excipients list |
DailyMed Link: | ATROPINE at DailyMed |
![ATROPINE drug patent expirations Drug patent expirations by year for ATROPINE](/p/graph/s/t/ATROPINE-patent-expirations.png)
![Drug Prices for ATROPINE](/p/graph/drug-price/ATROPINE.png)
Recent Clinical Trials for ATROPINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Stanford University | Phase 1 |
Pennsylvania College of Optometry | Phase 1 |
University of the Incarnate Word | Phase 1 |
Medical Subject Heading (MeSH) Categories for ATROPINE
Anatomical Therapeutic Chemical (ATC) Classes for ATROPINE
US Patents and Regulatory Information for ATROPINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL | 209260-001 | Jan 26, 2018 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL | 213561-001 | Dec 1, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbvie | ATROPINE | atropine | SOLUTION;INTRAMUSCULAR | 071295-001 | Jan 30, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |